Global smart pills market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
The major factors contributing to the growth of the market includes factors such as increasing prevalence of gastrointestinal disorders, rising cancer screening awareness programs and technological advancements and R&D investment in smart pills market.
The key market players for global smart pills market are listed below:
- Medtronic
- Otsuka Holdings Company Limited
- Olympus Corporation
- CapsoVision Inc.
- Check-Cap
- IntroMedic
- JINSHAN Science & Technology
- Lucid Group Limited
The market is further segmented into:
- Application
- Disease Indication
- Type
- End User
The global smart pills market is segmented on the basis of application into capsule endoscopy, drug delivery and patient monitoring of cancer. In 2018, capsule endoscopy segment is expected to dominate the smart pills market with 57.4% market share growing at the highest CAGR in the forecast period 2018 to 2025.
The global smart pills market is segmented on the basis of application into capsule endoscopy, drug delivery and patient monitoring of cancer. In 2018, capsule endoscopy segment is expected to dominate the market.
The global smart pills market is segmented on the basis of disease indication into occult GI bleeding, crohn's disease, small bowel tumors, celiac disease, inherited polyposis syndromes, mental disorders. In 2018, occult GI bleeding segment is expected to dominate the market.
The global smart pills market is segmented on the basis of type into multiparameter monitoring and single parameter monitoring. In 2018, multiparameter monitoring segment is expected to dominate the market in the forecast period.
The global smart pills market is segmented on the basis of end user into hospital, diagnostic centers and others. In 2018, hospital segment is expected to dominate the market
Based on geography, the market is segmented into 5 geographical regions:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Covered in this report
The report covers the present scenario and the growth prospects of the global smart pills for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
TABLE OF CONTENTS
1 INTRODUCTION 18
- 1.1 OBJECTIVES OF THE STUDY 18
- 1.2 MARKET DEFINITION 18
- 1.3 OVERVIEW OF GLOBAL SMART PILLS MARKET 18
- 1.4 CURRENCY AND PRICING 19
- 1.5 LIMITATION 19
- 1.6 MARKETS COVERED 20
2 MARKET SEGMENTATION 22
- 2.1 MARKETS COVERED 22
- 2.2 GEOGRAPHIC SCOPE 23
- 2.3 YEARS CONSIDERED FOR THE STUDY 24
- 2.4 CURRENCY AND PRICING 24
- 2.5 RESEARCH METHODOLOGY 25
- 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 28
- 2.7 SECONDARY SOURCES 29
- 2.8 ASSUMPTIONS 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 33
5 MARKET OVERVIEW 35
- 5.1 DRIVERS 37
- 5.1.1 INCREASING PREVALENCE OF GASTROINTESTINAL DISORDERS 37
- 5.1.2 RISING CANCER SCREENING AWARENESS PROGRAMS 38
- 5.1.3 TECHNOLOGICAL ADVANCEMENTS AND R&D INVESTMENT IN SMART PILLS MARKET 38
- 5.1.4 FAVOURABLE REIMBURSEMENT POLICIES FOR CAPSULE ENDOSCOPY 39
- 5.1.5 RISING NEED OF MINIMALLY INVASIVE SURGERIES 40
- 5.2 RESTRAINTS 41
- 5.2.1 HIGH COSTS OF SMART PILLS 41
- 5.2.2 ETHICAL CONCERNS RELATED TO SMART PILLS FOR DRUG DELIVERY 41
- 5.3 OPPORTUNITIES 42
- 5.3.1 NEED FOR RAPID DRUG DEVELOPMENT PROCESS 42
- 5.3.2 RISING NEED FOR THE FOCUS AND MOTIVATION IN DAILY LIFE FOR PEOPLE 42
- 5.4 CHALLENGES 43
- 5.4.1 LACK OF TRAINED STAFF 43
- 5.4.2 POSSIBLE HEALTH RISK ASSOCIATED WITH A SMART PILL INSERTED INTO A BODY 44
6 GLOBAL SMART PILLS MARKET, BY APPLICATION 45
- 6.1 OVERVIEW 46
- 6.2 CAPSULE ENDOSCOPY 48
- 6.2.1 SMALL BOWEL CAPSULE ENDOSCOPY 49
- 6.2.2 COLON CAPSULE ENDOSCOPY 49
- 6.3 DRUG DELIVERY 49
- 6.4 PATIENT MONITORING OF CANCER 50
7 GLOBAL SMART PILLS MARKET, BY DISEASE INDICATION 51
- 7.1 OVERVIEW 52
- 7.2 OCCULT GI BLEEDING 53
- 7.3 CROHN'S DISEASE 54
- 7.4 SMALL BOWEL TUMORS 55
- 7.5 CELIAC DISEASE 56
- 7.6 INHERITED POLYPOSIS SYNDROMES 57
- 7.7 MENTAL DISORDERS 58
8 GLOBAL SMART PILLS MARKET, BY TYPE 59
- 8.1 OVERVIEW 60
- 8.2 MULTIPARAMETER MONITORING 62
- 8.3 SINGLE PARAMETER MONITORING 63
9 GLOBAL SMART PILLS MARKET, BY END USER 64
- 9.1 OVERVIEW 65
- 9.2 HOSPITAL 66
- 9.3 DIAGNOSTIC CENTERS 67
- 9.4 OTHERS 68
10 GLOBAL SMART PILLS MARKET, BY GEOGRAPHY 69
- 10.1 GLOBAL 70
- 10.2 NORTH AMERICA 74
- 10.2.1 U.S. 81
- 10.2.2 CANADA 84
- 10.2.3 MEXICO 87
- 10.3 EUROPE 90
- 10.3.1 GERMANY 97
- 10.3.2 FRANCE 100
- 10.3.3 U.K. 103
- 10.3.4 ITALY 106
- 10.3.5 SPAIN 109
- 10.3.6 SWITZERLAND 112
- 10.3.7 NETHERLANDS 115
- 10.3.8 RUSSIA 118
- 10.3.9 BELGIUM 121
- 10.3.10 TURKEY 124
- 10.3.11 REST OF EUROPE 127
- 10.4 ASIA PACIFIC 128
- 10.4.1 CHINA 135
- 10.4.2 JAPAN 138
- 10.4.3 INDIA 141
- 10.4.4 SOUTH KOREA 144
- 10.4.5 AUSTRALIA 147
- 10.4.6 SINGAPORE 150
- 10.4.7 THAILAND 153
- 10.4.8 MALAYSIA 156
- 10.4.9 INDONESIA 159
- 10.4.10 PHILIPPINES 162
- 10.4.11 REST OF ASIA PACIFIC 165
- 10.5 SOUTH AMERICA 166
- 10.5.1 BRAZIL 173
- 10.5.2 REST OF SOUTH AMERICA 176
- 10.6 MIDDLE EAST AND AFRICA 177
- 10.6.1 SOUTH AFRICA 184
- 10.6.2 REST OF MIDDLE EAST & AFRICA 187
11 GLOBAL SMART PILLS MARKET, COMPANY LANDSCAPE 188
- 11.1 COMPANY SHARE ANALYSIS: GLOBAL 188
- 11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 189
- 11.3 COMPANY SHARE ANALYSIS: EUROPE 190
- 11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 191
12 COMPANY PROFILE 192
- 12.1 MEDTRONIC 192
- 12.1.1 COMPANY OVERVIEW 192
- 12.1.2 REVENUE ANALYSIS 192
- 12.1.3 COMPANY SHARE ANALYSIS 193
- 12.1.4 PRODUCT PORTFOLIO 193
- 12.1.5 RECENT DEVELOPMENTS 193
- 12.2 OTSUKA HOLDINGS COMPANY LIMITED 194
- 12.2.1 COMPANY OVERVIEW 194
- 12.2.2 REVENUE ANALYSIS 194
- 12.2.3 COMPANY SHARE ANALYSIS 195
- 12.2.4 PRODUCT PORTFOLIO 195
- 12.2.5 RECENT DEVELOPMENTS 195
- 12.3 OLYMPUS CORPORATION 196
- 12.3.1 COMPANY OVERVIEW 196
- 12.3.2 REVENUE ANALYSIS 196
- 12.3.3 COMPANY SHARE ANALYSIS 197
- 12.3.4 PRODUCT PORTFOLIO 197
- 12.3.5 RECENT DEVELOPMENTS 197
- 12.4 CAPSOVISION, INC. 198
- 12.4.1 COMPANY OVERVIEW 198
- 12.4.2 PRODUCT PORTFOLIO 198
- 12.4.3 RECENT DEVELOPMENTS 199
- 12.5 CHECK CAP 200
- 12.5.1 COMPANY OVERVIEW 200
- 12.5.2 GEOGRAPHIC PRESENCE 200
- 12.5.3 PRODUCT PORTFOLIO 201
- 12.5.4 RECENT DEVELOPMENTS 201
- 12.6 INTROMEDIC 202
- 12.6.1 COMPANY OVERVIEW 202
- 12.6.2 PRODUCT PORTFOLIO 202
- 12.6.3 RECENT DEVELOPMENTS 202
- 12.7 JINSHAN SCIENCE & TECHNOLOGY 203
- 12.7.1 COMPANY OVERVIEW 203
- 12.7.2 PRODUCT PORTFOLIO 203
- 12.7.3 RECENT DEVELOPMENTS 203
- 12.8 LUCID GROUP LIMITED 204
- 12.8.1 COMPANY OVERVIEW 204
- 12.8.2 PRODUCT PORTFOLIO 204
- 12.8.3 RECENT DEVELOPMENTS 204
13 RELATED REPORTS 205
